James Sidoti
Stock Analyst at Sidoti & Co.
(3.05)
# 1,255
Out of 4,670 analysts
8
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Downgrades: Neutral | $43 | $39.33 | +9.33% | 1 | May 29, 2024 | |
| STAA STAAR Surgical Company | Upgrades: Buy | n/a | $26.68 | - | 2 | Nov 7, 2022 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $1.01 | +395.05% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $107.97 | -68.51% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $16.97 | +259.46% | 2 | Jan 21, 2020 |
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $39.33
Upside: +9.33%
STAAR Surgical Company
Nov 7, 2022
Upgrades: Buy
Price Target: n/a
Current: $26.68
Upside: -
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $1.01
Upside: +395.05%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $107.97
Upside: -68.51%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $16.97
Upside: +259.46%